Literature DB >> 9094661

Functional interactions between papillomavirus E1 and E2 proteins.

M Berg1, A Stenlund.   

Abstract

DNA replication of papillomaviruses requires the viral E1 and E2 proteins. These proteins bind cooperatively to the viral origin of replication (ori), which contains binding sites for both proteins, forming an E1-E2-ori complex which is essential for initiation of DNA replication. To map the domains in E2 that are involved in the interaction with E1, we have used chimeric bovine papillomavirus (BPV)/human papillomavirus type 11 (HPV-11) E2 proteins. The results from this study show that both the DNA binding domain and the transactivation domain from BPV E2 independently can interact with BPV E1. However, the roles of these two interactions are different: the interaction between E1 and the activation domain of E2 is necessary and sufficient for cooperativity in binding and for DNA replication; the interaction between E1 and the DNA binding domain of E2 is required only when the binding sites for E1 and E2 are adjacent to each other, and the function of this interaction appears to be to facilitate the interaction between E1 and the transactivation domain of E2. These results indicate that the cooperative binding of E1 and E2 to the BPV ori takes place via a novel two-stage mechanism where one interaction serves as a trigger for the formation of the second, productive, interaction between the two proteins.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9094661      PMCID: PMC191536     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  61 in total

1.  Transcription factors NFI and NFIII/oct-1 function independently, employing different mechanisms to enhance adenovirus DNA replication.

Authors:  Y M Mul; C P Verrijzer; P C van der Vliet
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

2.  The 68-kilodalton E1 protein of bovine papillomavirus is a DNA binding phosphoprotein which associates with the E2 transcriptional activator in vitro.

Authors:  I L Blitz; L A Laimins
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

3.  Differential transcriptional activation by Oct-1 and Oct-2: interdependent activation domains induce Oct-2 phosphorylation.

Authors:  M Tanaka; W Herr
Journal:  Cell       Date:  1990-02-09       Impact factor: 41.582

4.  Targeting the E1 replication protein to the papillomavirus origin of replication by complex formation with the E2 transactivator.

Authors:  I J Mohr; R Clark; S Sun; E J Androphy; P MacPherson; M R Botchan
Journal:  Science       Date:  1990-12-21       Impact factor: 47.728

5.  Transactivation of a bovine papilloma virus transcriptional regulatory element by the E2 gene product.

Authors:  B A Spalholz; Y C Yang; P M Howley
Journal:  Cell       Date:  1985-08       Impact factor: 41.582

6.  Binding of a simian virus 40 T antigen-related protein to DNA.

Authors:  R D McKay
Journal:  J Mol Biol       Date:  1981-01-25       Impact factor: 5.469

7.  Interactions between the adenovirus type 2 DNA polymerase and the DNA binding domain of nuclear factor I.

Authors:  J Bosher; E C Robinson; R T Hay
Journal:  New Biol       Date:  1990-12

8.  Functional dissection of a eukaryotic transcriptional activator protein, GCN4 of yeast.

Authors:  I A Hope; K Struhl
Journal:  Cell       Date:  1986-09-12       Impact factor: 41.582

9.  Activation of polyomavirus DNA replication by yeast GAL4 is dependent on its transcriptional activation domains.

Authors:  E R Bennett-Cook; J A Hassell
Journal:  EMBO J       Date:  1991-04       Impact factor: 11.598

10.  Transient replication of BPV-1 requires two viral polypeptides encoded by the E1 and E2 open reading frames.

Authors:  M Ustav; A Stenlund
Journal:  EMBO J       Date:  1991-02       Impact factor: 11.598

View more
  45 in total

1.  Separate domains in E1 and E2 proteins serve architectural and productive roles for cooperative DNA binding.

Authors:  E Gillitzer; G Chen; A Stenlund
Journal:  EMBO J       Date:  2000-06-15       Impact factor: 11.598

2.  Two patches of amino acids on the E2 DNA binding domain define the surface for interaction with E1.

Authors:  G Chen; A Stenlund
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  Sequential and ordered assembly of E1 initiator complexes on the papillomavirus origin of DNA replication generates progressive structural changes related to melting.

Authors:  Grace Chen; Arne Stenlund
Journal:  Mol Cell Biol       Date:  2002-11       Impact factor: 4.272

4.  The inhibitory action of P56 on select functions of E1 mediates interferon's effect on human papillomavirus DNA replication.

Authors:  Paramananda Saikia; Volker Fensterl; Ganes C Sen
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

5.  E1 initiator DNA binding specificity is unmasked by selective inhibition of non-specific DNA binding.

Authors:  Arne Stenlund
Journal:  EMBO J       Date:  2003-02-17       Impact factor: 11.598

6.  Cooperative activation of human papillomavirus type 8 gene expression by the E2 protein and the cellular coactivator p300.

Authors:  Andreas Müller; Andreas Ritzkowsky; Gertrud Steger
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

7.  Identification of a short, hydrophilic amino acid sequence critical for origin recognition by the bovine papillomavirus E1 protein.

Authors:  A Gonzalez; C Bazaldua-Hernandez; M West; K Woytek; V G Wilson
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

8.  Bromodomain protein 4 mediates the papillomavirus E2 transcriptional activation function.

Authors:  Michal-Ruth Schweiger; Jianxin You; Peter M Howley
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

Review 9.  The E1 proteins.

Authors:  Monika Bergvall; Thomas Melendy; Jacques Archambault
Journal:  Virology       Date:  2013-09-10       Impact factor: 3.616

10.  Distinct roles of two binding sites for the bovine papillomavirus (BPV) E2 transactivator on BPV DNA replication.

Authors:  T G Gillette; J A Borowiec
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.